Status:
TERMINATED
Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Blood Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hematopoietic stem cell transplantation (HCT) has the potential to cure a variety of malignant and non-malignant diseases. However, it is associated with significant morbidity, and treatment-related m...
Detailed Description
The patient-centered medical home (PCMH) is an exciting strategy that has the potential to revolutionize hematopoietic stem cell transplantation (HCT). Traditionally, home care has been used for palli...
Eligibility Criteria
Inclusion
- Scheduled to undergo a hematopoietic stem cell transplant for any cancer or non-cancer illness
- Age 18-80 years of age
- Karnofsky Performance Scale (KPS)\> 80
- A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke
Exclusion
- Lack of a caregiver
- Pregnant women
- Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
- Use of homeopathic medications or probiotics that may impact gut microbiota
Key Trial Info
Start Date :
September 3 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2022
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT02218151
Start Date
September 3 2014
End Date
February 14 2022
Last Update
November 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Adult Bone Marrow Transplant Clinic
Durham, North Carolina, United States, 27705